Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells
The present invention provides a peptide containing eight or more consecutive amino acid residues in an amino acid sequence represented by any of SEQ ID NOS: 1-11 and comprising 11 or fewer amino acid residues.